Samos Investments — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Shennon Biotechnologiesshennonbio.cominDec 2022
ShennonBio develops immunotherapy technologies using microfluidic engineering, computational biology, and immunology to advance T cell engineering for cancer treatment.
AI & Machine LearningBiotechDeep TechMedical DevicesSan Francisco, US
Li Sun, PhD(Founder/CEO)inJAMES HARDIMAN(Director)LI SUN(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.